ロード中...
The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
Checkpoint immunotherapy that targets inhibitory receptors of T cells, thereby reversing the functional exhaustion of T cells, marks a breakthrough in anticancer therapy. The success of T cell-directed checkpoint inhibitors of CTLA-4 and PD-1/PD-L1 has opened a new approach for cancer immunotherapy...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6812684/ https://ncbi.nlm.nih.gov/pubmed/31681269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02354 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|